Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2026-02-03 00:00:00 ET · period of report 2026-01-30 · accession 0001628280-26-005155 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-03 | 2026-01-30 | PCRX | SLONIN JONATHAN | Chief Medical Off | F - Tax | $20.54 | -6,168 | 172.4K | -3% | -$126.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-30 | F | D | 6,168 | $20.54 | 172,355.18 | D | — | — | (F1) Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. |